Earnings Estimates Moving Higher for Mesa Labs (MLAB): Time to Buy?

In this article:

Mesa Labs (MLAB) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company.

The rising trend in estimate revisions, which is a result of growing analyst optimism on the earnings prospects of this quality control instruments and disposable products maker, should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Our stock rating tool -- the Zacks Rank -- is principally built on this insight.

The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.

For Mesa Labs, strong agreement among the covering analysts in revising earnings estimates upward has resulted in meaningful improvement in consensus estimates for the next quarter and full year.

The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:

12 Month EPS

Current-Quarter Estimate Revisions

The earnings estimate of $2.10 per share for the current quarter represents a change of +54.41% from the number reported a year ago.

Over the last 30 days, the Zacks Consensus Estimate for Mesa Labs has increased 20.92% because two estimates have moved higher compared to no negative revisions.

Current-Year Estimate Revisions

For the full year, the company is expected to earn $9.15 per share, representing a year-over-year change of +28.87%.

There has been an encouraging trend in estimate revisions for the current year as well. Over the past month, two estimates have moved up for Mesa Labs versus no negative revisions. This has pushed the consensus estimate 23.95% higher.

Favorable Zacks Rank

The promising estimate revisions have helped Mesa Labs earn a Zacks Rank #1 (Strong Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.

Bottom Line

Investors have been betting on Mesa Labs because of its solid estimate revisions, as evident from the stock's 30.5% gain over the past four weeks. As its earnings growth prospects might push the stock higher, you may consider adding it to your portfolio right away.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Mesa Laboratories, Inc. (MLAB) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Advertisement